Current concepts in the management of hemophilia

Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study Group.

Haemophilia : the official journal of the World Federation of Hemophilia·1999

Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.

Thrombosis and haemostasis·1996

Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group.

Blood·1994

Medical management of extensive spinal epidural hematoma in a child with factor IX deficiency.

Pediatric emergency care·1994

Alpha 2-antiplasmin deficiency. An overlooked cause of hemorrhage.

The American journal of pediatric hematology/oncology·1993

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group.

The New England journal of medicine·1993

Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.

Seminars in hematology·2026

The current state of cerebral complications of sickle cell disease.

Seminars in hematology·2026

Blood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.

Seminars in hematology·2026

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Seminars in hematology·2026

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.

Seminars in hematology·2026

Germline predisposition in myeloproliferative neoplasms.

Seminars in hematology·2026

Serum Retinol-Binding Protein 4 Levels in Hypertensive and Normotensive Individuals.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026

Hereditary angioedema in women: Hormonal and reproductive influences on disease activity.

Allergy and asthma proceedings·2026

Outcomes of patients with myelofibrosis treated with ruxolitinib and anemia-supporting medications.

Hematology (Amsterdam, Netherlands)·2026

Prognostic Value of Admission D-dimer Levels and Total Bleeding Volume in Aneurysmal Subarachnoid Hemorrhage: A Retrospective Cohort Study with Machine Learning-Based Modeling.

Neurocritical care·2026

Conditioning Intensity and Outcomes in Pediatric HLA-Identical Transplant for Sickle Cell Disease: Comparison of MAC, RIC, and NMA.

Transplantation and cellular therapy·2026

Impact of Gastrointestinal Bleeding History on Postoperative Outcomes in Total Hip and Knee Arthroplasty: A Retrospective Analysis.

The Journal of arthroplasty·2026

Related Experiment Videos

Current concepts in the management of hemophilia

Related Concept Videos

Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study Group.

Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.

Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group.

Medical management of extensive spinal epidural hematoma in a child with factor IX deficiency.

Alpha 2-antiplasmin deficiency. An overlooked cause of hemorrhage.

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group.

Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.

The current state of cerebral complications of sickle cell disease.

Blood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.

Germline predisposition in myeloproliferative neoplasms.

Serum Retinol-Binding Protein 4 Levels in Hypertensive and Normotensive Individuals.

Hereditary angioedema in women: Hormonal and reproductive influences on disease activity.

Outcomes of patients with myelofibrosis treated with ruxolitinib and anemia-supporting medications.

Prognostic Value of Admission D-dimer Levels and Total Bleeding Volume in Aneurysmal Subarachnoid Hemorrhage: A Retrospective Cohort Study with Machine Learning-Based Modeling.

Conditioning Intensity and Outcomes in Pediatric HLA-Identical Transplant for Sickle Cell Disease: Comparison of MAC, RIC, and NMA.

Impact of Gastrointestinal Bleeding History on Postoperative Outcomes in Total Hip and Knee Arthroplasty: A Retrospective Analysis.

Related Experiment Videos

Current concepts in the management of hemophilia

Related Concept Videos

Related Articles